| 中文别名 |
盐酸帕罗西汀半水合物;5,7-二溴-8-羟基喹啉;Paroxetine Hydrochloride Hemihydrate 盐酸帕罗西汀半水合物;半水帕罗西汀;盐酸帕罗西汀;盐酸帕罗西汀 USP标准品;盐酸帕罗西汀 标准品;(-)-反式-4-(4-氟苯基)-3-{[3,4-(亚甲二氧基)苯氧基]甲基}-哌啶盐酸盐;(-)-反式-4R-(4-氟苯基)-3S-{[3',4'-(亚甲二氧基)苯氧基]甲基}-哌啶盐酸盐半水合物;(3S,4R)-(-)-3-[(1,3-苯并二恶茂-5-基氧)甲基]-4-(4-氟苯基)哌啶盐酸盐;帕罗西汀,盐酸D4;(3S,4R)-(-)-3-[(1,3-苯并二恶茂-5-基氧)甲基]-4-(4-氟苯基)哌啶盐酸盐 半水合物;帕罗西汀盐酸盐半水合物;D4-盐酸帕罗西汀;盐酸帕罗西汀半水合物, 选择性5-羟色胺重吸收抑制剂 (SSRI);盐酸帕罗西汀(半水合物) |
| 英文别名 |
Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate(2:2:1), (3S,4R)-;Paroxetine hydrochloride hemihydrate;Paroxetine (hydrochloride hemihydrate);Paroxetine HCl;Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate(2:2...;BRL29060 hydrochloride hemihydrate;BRL29060A hemihydrate;PAROXETINE HEMIHYDRATE, EP;Paroxetine hydrochl;Paroxetine hydrochloride;PAROXETINE-D4 HCL;USP;(3S-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride hemihydrate;(3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride Hemihydrate;(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine hydrochloride hemihydrate;PAROXETINE HCL HEMIHYDRATE;Paroxetine-D4 hydrochloride;paroxetine hydrochloride hydrate;Paroxetine Hydrochloride (350 mg);2H2O;PAROXETINE HYDROCHLORIDE 1;Paxil;Paroxat;paroxetine (hydrochloride);Aropax 20;(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride;BRL 29060 hydrochloride;Aropax;Paroxetine hydrochloride [USP];BRL29060A;BRL 29060A;SDB 7175;3I3T11UD2S;Paroxetine hydrochloride hemihydrate (MW = 374.83);S3005;Paxil (TN);C19H21ClFNO3;Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-;Seroxat;Piperidine, 3-((1,3-benzodioxol-5-yloxy);Deroxat;Paroxetine HCl hydrate;AKOS015962357;PAROXETINE HYDROCHLORIDE [USP-RS];PAROXETINE HYDROCHLORIDE HEMIHYDRATE [USP MONOGRAPH];Paroxetine.HCl.hemihydrate;PAROXETINE HYDROCHLORIDE [VANDF];(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidin-1-ium;chloride;PAROXETINE HYDROCHLORIDE HEMIHYDRATE [EP MONOGRAPH];DTXSID101017095;UNII-X2ELS050D8;Q27293431;PAROXETINE HYDROCHLORIDE HEMIHYDRATE [MI];(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride hemihydrate;PAROXETINE HYDROCHLORIDE HEMIHYDRATE [WHO-DD];NCGC00181791-01;PAROXETINE HYDROCHLORIDE [ORANGE BOOK];KS-1094;(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrate;dihydrochloride;(-)-(3S,4R)-4-(P-FLUOROPHENYL)-3-((3,4-METHYLENEDIOXY)PHENOXY)-METHYL)PIPERIDINE HYDROCHLORIDE HEMIHYDRATE;Paroxetine Hydrochloride Hemihydrate 1.0 mg/ml in Methanol (as anhydrous free base);X2ELS050D8;Paroxetine hydrochloride hydrate;Paroxetine.HCl.hemihydrate, 1mg/ml in Methanol;Paroxetine hydrochloride hemihydrate (USP);PAROXETINE HYDROCHLORIDE HYDRATE [JAN];AC-16708;(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloridehemihydrate;110429-35-1;Paroxetine hydrochloride hydrate (JP17);D02260 |
微信公众号
客服
C(%3dO)C%3dC(O2)C(%3dO)O)
CC2C1(CCC3C2(CCC(%3dO)C3(C)C)C)C)C)C%3dCC(%3dO)O)
C(%3dO)NCCCCCCCC(%3dO)%5bO-%5d)O.%5bNa%2b%5d)
Cl)
N)%5cC(%3dO)N%5bC%40H%5d2%5bC%40%40H%5d3N(C2%3dO)C(%3dC(CS3)CSC(%3dO)C4%3dCC%3dCO4)C(%3dO)%5bO-%5d.%5bNa%2b%5d)
